Cancer in the News

Feb 21, 2012

Better Understanding Of Cancer Drugs Following Discovery Of Cell Energy Sensor Mechanism

Johns Hopkins and National Taiwan University researchers have discovered more details about how an energy sensing "thermostat" protein determines whether cells will store or use their energy reserves. In a report in Nature, the researchers showed that a chemical modification on the thermostat protein changes how it's controlled... Read More
Feb 21, 2012

Strengthening The Intestinal Barrier May Prevent Cancer In The Rest Of The Body

A leaky gut may be the root of some cancers forming in the rest of the body, a new study published online Feb. 21 in PLoS ONE by Thomas Jefferson University researchers suggests... Read More
Feb 21, 2012

Drugs That Affect Serotonin Signaling May Combat Bone Loss

Scientists have long known that calcium leaches from the bones both during lactation and in certain types of cancer. The driver behind these phenomena is a molecule called parathyroid hormone related protein (PTHrP), which is secreted by the mammary glands. The signal that regulates the secretion of PTHrP, and where this other unknown molecule exerts its influence, has remained a mystery... Read More
Feb 21, 2012

Prostate Cancer Progression Driven By Telomere Failure, Telomerase Activation

Genomic instability caused by an erosion of the protective caps on chromosomes, followed by activation of an enzyme that reinforces those caps, allows malignant cells to evade destruction and acquire more deadly characteristics, researchers report in an Online Now article at the journal Cell... Read More
Feb 21, 2012

First Model Of Aggressive Ovarian Cancer Demonstrates Immune System's Active Role In Tumor Progression

Aggressive ovarian tumors begin as malignant cells kept in check by the immune system until, suddenly and unpredictably, they explode into metastatic cancer. New findings from scientists at The Wistar Institute demonstrate that ovarian tumors don't necessarily break "free" of the immune system, rather dendritic cells of the immune system seem to actively support the tumor's escape... Read More
Feb 21, 2012

Early Cancer Detection Via New Blood Test: Research In The Early Stages Of Clinical Trials

A simple blood test is being developed by researchers at Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beer-Sheva, Israel that may provide early detection of many types of cancer. Prof. Kapelushnik of BGU's Faculty of Health Sciences and his team developed a device that illuminates cancer cells with less than a teaspoon of blood... Read More
Feb 21, 2012

Identification Of 'Stealth' Properties Of Cancer-Causing Genetic Mutations

Scientists have discovered that cancer-causing genetic mutations have better-disguised electronic signatures than other mutations - a trait which could help them fly under the radar of the body's defence mechanisms... Read More
Feb 21, 2012

Possible New Target For Cancer Therapy - Energy Network Within Cells

Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to a new study. Manipulation of two biochemical signals that regulate the numbers of mitochondria in cells could shrink human lung cancers transplanted into mice, a team of Chicago researchers report in the journal FASEB... Read More
Feb 21, 2012

Cancer Cells Destroyed By Blocking Telomerase But Resistance, Progression Provoked

Inhibiting telomerase, an enzyme that rescues malignant cells from destruction by extending the protective caps on the ends of chromosomes, kills tumor cells but also triggers resistance pathways that allow cancer to survive and spread, scientists report in Cell... Read More
Feb 21, 2012

Potential For Development Of Tailor-Made Anticancer Agents Following Mapping Of Protein Inhibitors

A team of researchers at Karolinska Institutet has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism behind putative side effects of the so-called PARP inhibitors, and can play an important role in the development of novel tailor-made cancer drugs... Read More
Next Page